Caredx Inc CDNA

$71.92 -2.52 (-3.39%)

Valuation

Market cap
3,911,300,000
Revenue TTM
$379,810,000
Net income TTM
$-21,350,000
P/E (trailing)
112.97
P/E (forward)
74.19
Profit margin
-5.62%
Debt to equity
0.00

Trading

Volume
879,300
Avg volume
1,336,018
Day's range
$71.59 – $76.90
Shares out
52,543,000
Stochastic %K
2%
Beta
2.51
Analysts
Strong Buy
Price target
$94.43

Price

Company profile

CareDx, Inc. provides solutions for improving outcomes for transplant patients and advancing organ health in the United States and internationally. The company provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression profiling solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients; an...

Show more

CareDx, Inc. provides solutions for improving outcomes for transplant patients and advancing organ health in the United States and internationally. The company provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression profiling solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients; and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. It also offers HeartCare, which provides information about distinct biological processes, such as immune quiescence, active injury, acute cellular rejection, and antibody mediated rejection; HistoMap Kidney, a solution that identifies allograft rejection and type of rejection in kidney transplant biopsy tissue; and AlloHeme, a monitoring test that predicts relapse in patients with acute myeloid leukemia and myelodysplastic syndromes. In addition, the company provides QTYPE that enables precision in human leukocyte antigen (HLA) typing; Olerup SSP, which is used to type HLA alleles based on sequence specific primer technology; and Ottr, a transplant patient management software. Further, it offers AlloSeq Tx, a high-resolution HLA typing solution; AlloSeq cfDNA, a surveillance solution to measure dd-cfDNA in blood; AlloSeq HCT, a solution for chimerism testing for stem cell transplant recipients; Allocell, a solution that monitors the pharmacokinetics of engraftment and persistence of cells for patients who have received allogeneic cell therapy; and XynQAPI, MedActionPlan, CareDx pharmacy, AlloHome, and HLA Data Systems software solutions. It has a license agreement with Illumina, Inc. for the distribution, development, and commercialization of NGS products and technologies. The company was formerly known as XDx, Inc. and changed its name to CareDx, Inc. in March 2014. The company was incorporated in 1998 and is headquartered in Brisbane, California.

Industry
Diagnostics & Research
Sector
Healthcare
Phone
415 287 2300
Website
https://caredx.com
Address
8000 Marina Boulevard, Brisbane, United States

Latest news

Stocktwits

BuyNowUnlimited Nov 20, 12:54 AM
$CDNA whys healthcare also crashing alongside ai stocks …. bullshit
0 replies
StockConsultant Nov 19, 2:22 PM
Before the open, stocks at support Strong pre market for stocks, did a quick scan for stocks at support with good trade quality : $CDNA $EXEL GVA ICLR $MMM $PRCH and $ROIV at https://www.stockconsultant.com/?CDNA
0 replies
Pavie99 Nov 18, 1:26 PM
$CDNA this one is dreaming. Flash in the pan
0 replies
shoc24 Nov 16, 7:23 PM
$CDNA is ranked #4 in healthcare momentum with a score of 89. I used Stock Meadow's scoring model. Build your own model and backtest it if you don't agree with mine.
0 replies
theflynews Nov 11, 2:07 PM
Pre-Market Fly By for Wednesday, November 11th: Breaking Stock Market News $CRWV $NVDA $CDNA $MP $MRCY
0 replies
IrenGlazer69 Nov 9, 9:23 PM
$CDNA we re so back 💪
0 replies
GTA_Terminal Nov 8, 7:15 AM
Dark pool check on $CDNA: what traded off the exchanges in the latest session. The stock moved +2.9% on the day, so this wasn't happening in a quiet tape. Look up any stock's options flow and dark pools on the GTA Terminal, free for 7 days: https://globaltradersacademy.com/start-trial?a=stocktwits&sym=CDNA&utm_source=stocktwits&utm_medium=social&utm_campaign=trial&utm_content=CDNA Read the full article for the full details: https://globaltradersacademy.com/articles/dark-pool-check-caredx-cdna?utm_source=stocktwits&utm_medium=social
0 replies
IrenGlazer69 Nov 6, 2:40 PM
$CDNA road to 100
0 replies